Stock Quote
inVentiv Health, Inc. (VTIV.O) (Nasdaq)
$16.42
4:00pm EST
+1.99%
$16.10
$16.17
124,941
$16.59
$16.10
$18.97
$6.60
1.27
178,739
VTIV.O
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Broshy, Eran | Executive Chairman of the Board | 1,429,410 |
| Walter, R. Blane | Chief Executive Officer, Director | 2,888,030 |
| Bassin, David | Chief Financial Officer, Secretary | 1,415,600 |
Profile
inVentiv Health Inc. (inVentiv) is a provider of value-added services to the pharmaceutical, life sciences and healthcare industries. The Company supports a range of clinical development, communications and commercialization activities that are critical to its customers' ability to complete the... Full Description
Company Address
inVentiv Health, Inc.
200 Cottontail Lane
Vantage Court North
Somerset NJ 08873
P: +1800.4160555
200 Cottontail Lane
Vantage Court North
Somerset NJ 08873
P: +1800.4160555
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Cross Country Healthcare, Inc. | $8.85 | +0.18 |
| ICON plc | €15.10 | 0.00 |
| ASG Group Limited | $1.04 | -0.01 |
| VTIV.O | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.93 |
| P/S(TTM) | 0.50 | 0.27 |
| ROI(TTM) | -15.04 | 2.04 |
| ROE(TTM) | -27.71 | 0.31 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 0.25 |
| EPS Est. (Current Year) | 1.34 |
| Total Revenue | $270.47M |
| Net Income | $11.93M |
| EPS | $0.35 |
